Advances in Vancomycin Resistance: Research inStaphylococcus aureus
- 30 April 2014
- book chapter
- Published by American Society for Microbiology
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitalsClinical Microbiology & Infection, 2004
- Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- Lack of Evidence for Involvement of Hypermutability in Emergence of Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Evolution of a Vancomycin-Intermediate Staphylococcus aureus Strain In Vivo: Multiple Changes in the Antibiotic Resistance Phenotypes of a Single Lineage of Methicillin-Resistant S . aureus under the Impact of Antibiotics Administered for ChemotherapyJournal of Clinical Microbiology, 2003
- Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in KoreaJournal of Clinical Microbiology, 2002
- Vancomycin-intermediate Staphylococcus aureus at a Scottish HospitalJournal of Infection, 2000
- Identification of the Up- and Down-Regulated Genes in Vancomycin-Resistant Staphylococcus aureus Strains Mu3 and Mu50 by cDNA Differential Hybridization MethodBiochemical and Biophysical Research Communications, 2000
- The Effects of Vancomycin and β-Lactam Antibiotics on Vancomycin-ResistantStaphylococcus aureusNew England Journal of Medicine, 1999
- Bacteremia Caused by Staphylococci with Inducible Vancomycin HeteroresistanceClinical Infectious Diseases, 1999
- Peptidoglycan cross‐linking in Staphylococcus aureusEuropean Journal of Biochemistry, 1990